VESIcare Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OAB
Conditions:   Benign Prostatic Hyperplasia;   Overactive Bladder Interventions:   Drug: Tadalafil 5mg;   Drug: Tamsulosin Hcl 0.4 mg;   Drug: solifenacin 10 mg Sponsor:   Mansoura University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2022 Category: Research Source Type: clinical trials